Ligand Pharmaceuticals reported $14.15M in Cost of Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Acorda Therapeutics ACOR:US USD 11M 2.2M
Agenus AGEN:US USD 308K 1.72M
Amgen AMGN:US USD 1.59B 78M
Anika Therapeutics ANIK:US USD 17.48M 2.69M
Baxter International BAX:US USD 2.63B 337M
Bristol Myers Squibb BMY:US USD 2.35B 324M
Clovis Oncology CLVS:US USD 8.61M 607K
Eli Lilly And LLY:US USD 1.58B 148.6M
Endo International Ordinary Shares ENDP:US USD 176.86M 1.06M
Gilead Sciences GILD:US USD 1.4B 47M
Glaxosmithkline GSK:US GBP 2.39B 250M
GlaxoSmithKline GSK:LN GBP 2.39B 250M
Harsco HSC:US USD 392.8M 10.4M
Heron Therapeutics HRTX:US USD 14.72M 1.46M
Insmed INSM:US USD 13.47M 2.92M
Intrexon XON:US USD 1.58M 234K
Karyopharm Therapeutics KPTI:US USD 980K 41K
Lannett LCI:US USD 62.48M 3.85M
Ligand Pharmaceuticals LGND:US USD 14.15M 1.79M
MacroGenics MGNX:US USD 3.14M 741K
Merk MRK:US USD 3.43B 715M
Pacira Pharmaceuticals PCRX:US USD 50.68M 51K
Pfizer PFE:US USD 6.09B 2.58B
Rigel Pharmaceuticals RIGL:US USD 250K 786K
Teva Pharmaceutical Industries TEVA:US USD 1.88B 73M
Veracyte VCYT:US USD 26.01M 978K